Clinton Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Clinton Group’s Portfolio VRTX Stock Details VRTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell
2018 Q1	$257K	Sell
2017 Q4	$5.78M	Buy
2017 Q3	$539K	Buy
2017 Q2	–	Sell
2017 Q1	$1.2M	Buy
2016 Q4	–	Sell
2016 Q3	$563K	Buy